Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.53 |
| ▸ | CNR1 | P21554 | 7/20 | 0.48 |
| ▸ | CFTR | P13569 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1464509 | 0.89 | CNR2 (0.66) | CNR2CNR1CFTRMAPT | |
| SCHEMBL3964897 | 0.86 | CNR2 (0.59) | CNR2CNR1MAPT | |
| SCHEMBL3961157 | 0.85 | CNR2 (0.40) | CNR2CNR1CFTRMAPT | |
| SCHEMBL1463634 | 0.83 | CNR2 (0.66) | CNR2CNR1 | |
| SCHEMBL1464511 | 0.80 | CNR2 (0.50) | CNR2CFTRMAPTKDM4EALDH1A1 | |
| SCHEMBL3968656 | 0.77 | CNR2 (0.58) | CNR2MAPTKDM4EALDH1A1LMNA | |
| SCHEMBL1464658 | 0.76 | CNR2 (0.71) | CNR2CNR1MAPT | |
| SCHEMBL4071291 | 0.76 | CNR2 (0.46) | CNR2CNR1LMNA | |
| SCHEMBL1620976 | 0.74 | CNR2 (0.43) | CNR2CFTRMAPTKDM4EALDH1A1 | |
| SCHEMBL4069777 | 0.73 | CNR2 (0.42) | CNR2CNR1MAPTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081905-A2 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-29 | — | — | EP | claimed |
| WO-2008014199-A2 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-01-31 | — | — | WO | claimed |